Skip to main content

Table 5 Regression results adjusted for variations at health facility level and seasonality, Jan 2016–Mar 2017

From: Effects and factors associated with indoor residual spraying with Actellic 300 CS on malaria morbidity in Lira District, Northern Uganda

Time in months in relation to IRS with Actellic 300 CS

Adjusted percentage point changes (pp) in confirmed Malaria

95% confidence interval

P-value

Percentage point changes before IRS intervention

 Jan 2016

Ref.

   

 Feb 2016

− 0.05

− 0.58

0.47

0.836

 March 2016

− 1.03

− 1.60

− 0.45

< 0.001

 April 2016

− 0.35

− 0.83

0.13

0.153

 May 2016

0.66

0.14

1.17

0.012

 June 2016

0.97

0.53

1.40

< 0.001

 July 2016

0.71

0.27

1.16

0.002

Percentage point changes after IRS intervention

 August (spray month)

Ref

   

 Sept (1 months after IRS)

− 0.07

− 0.98

0.84

0.878

 Oct (2 month after IRS)

− 0.18

− 1.09

0.74

0.702

 Nov (3 month after IRS)

− 0.13

− 1.04

0.78

0.781

 Dec (4 month after IRS)

− 0.39

− 0.85

0.05

0.085

 Jan 17 (5 month after IRS)

− 0.60

− 1.08

− 0.12

0.015

 Feb 17 (6 month after IRS)

− 1.19

− 1.79

− 0.60

< 0.001

 Mar 17 (7 month after IRS)

− 1.97

− 2.10

0.12

0.081

  1. Adj. pp = percentage point change in outpatient attendance due to confirmed Malaria, adjusted for seasonality and variation at health facility level